Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease

To report the efficacy of combination therapy (bevacizumab and photocoagulation) in a case of Eales Disease this study has been performed. Bevacizumab (Avastin, 1.25 mg/0.05 ml) was injected intravitreously for the treatment of iris and retinal neovascularization in a 56-year old Hispanic female wit...

Descripción completa

Detalles Bibliográficos
Autores principales: CP, Juarez, AL, Gramajo, JD, Luna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Hypothesis, Discovery & Innovation Ophthalmology 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939753/
https://www.ncbi.nlm.nih.gov/pubmed/24600639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939753/
https://www.ncbi.nlm.nih.gov/pubmed/24600639

Ejemplares similares